By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Bepotastine (monograph)
Drugs

Bepotastine (monograph)

https://themeditary.com/drug/bepotastine-monograph-7229.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Aug 15, 2023  Additional Content by TheMediTary.Com

Generic name: bepreve

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Bepreve eye drops, Bepotastine ophthalmic

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Bepotastine (monograph)?

Introduction

Histamine H 1-receptor antagonist with mass-cell stabilizing activity.

Uses for Bepotastine

Allergic Conjunctivitis

Symptomatic treatment of ocular itching associated with allergic conjunctivitis.

Bepotastine Dosage and Administration

Administration

Ophthalmic Administration

Apply topically to the eye as an ophthalmic solution.

Remove soft contact lenses prior to administration of each dose (since benzalkonium chloride may be absorbed by the lenses); may reinsert lenses after 10 minutes following administration if eyes are not red.

Avoid contamination of the solution container.

Dosage

Available as bepotastine besilate; dosage expressed in terms of the salt.

Pediatric Patients

Allergic Conjunctivitis
Ophthalmic

Children ≥2 years of age: 1 drop of a 1.5% solution in the affected eye(s) twice daily.

Adults

Allergic Conjunctivitis
Ophthalmic

1 drop of a 1.5% solution in the affected eye(s) twice daily.

Detailed Bepotastine ophthalmic dosage information

Warnings

Contraindications

  • Manufacturer states none known.

Warnings/Precautions

Administration

For topical ophthalmic use only.

Proper Handling to Avoid Contamination

To avoid contamination of the dropper tip and solution, do not to touch the eyelids or surrounding areas with the dropper tip.

Close container tightly when not in use.

Contact Lenses

Remove contact lenses prior to administration of each dose, since benzalkonium chloride preservative may be absorbed by soft contact lenses; lenses may be reinserted after 10 minutes following administration if eyes are not red; patient should not wear contact lenses if eyes are red. Not indicated for contact lens-related ocular irritation.

Specific Populations

Pregnancy

Category C.

Lactation

Distributed into milk in rats following oral administration.

Not known whether bepotastine besilate distributes into human milk following topical application to the eye. Use caution.

Pediatric Use

Safety and efficacy not established in pediatric patients <2 years of age. Efficacy in pediatric patients <10 years of age was extrapolated from clinical trials conducted in pediatric patients >10 years of age and adults.

Geriatric Use

No overall differences in efficacy or safety observed between geriatric and younger patients.

Common Adverse Effects

Mild taste following instillation, ocular irritation, headache, nasopharyngitis.

How should I use Bepotastine (monograph)

Administration

Ophthalmic Administration

Apply topically to the eye as an ophthalmic solution.

Remove soft contact lenses prior to administration of each dose (since benzalkonium chloride may be absorbed by the lenses); may reinsert lenses after 10 minutes following administration if eyes are not red.

Avoid contamination of the solution container.

Dosage

Available as bepotastine besilate; dosage expressed in terms of the salt.

Pediatric Patients

Allergic Conjunctivitis
Ophthalmic

Children ≥2 years of age: 1 drop of a 1.5% solution in the affected eye(s) twice daily.

Adults

Allergic Conjunctivitis
Ophthalmic

1 drop of a 1.5% solution in the affected eye(s) twice daily.

Detailed Bepotastine ophthalmic dosage information
Bepotastine (monograph) Dosage information (more detail)

More about Bepotastine (monograph) (Bepreve)

Dosage information
Bepotastine (monograph) Side Effects
During pregnancy
Bepotastine Eye Drops Prescribing Information
Drug images
Side effects
Breastfeeding Warnings
Drug class: Drugs

Patient resources

Bepotastine

Related treatment guides

Conjunctivitis, Allergic
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by